SARcode Biosciences' Series B Round

SARcode Biosciences raised a round of funding on July 12, 2011.

SARcode is a private, San Francisco based biotechnology company focused on the development of small molecule LFA-1 antagonists to treat inflammatory diseases. Targets include topical therapies for T-c…

Articles about SARcode Biosciences' Series B Round: